Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 193001-91-1 | MDL No. : | MFCD09029989 |
Formula : | C7H8ClNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LGAAPDVGNCACDI-UHFFFAOYSA-N |
M.W : | 173.60 | Pubchem ID : | 11457961 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.87 |
TPSA : | 42.35 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.49 cm/s |
Log Po/w (iLOGP) : | 1.74 |
Log Po/w (XLOGP3) : | 1.23 |
Log Po/w (WLOGP) : | 1.08 |
Log Po/w (MLOGP) : | 0.61 |
Log Po/w (SILICOS-IT) : | 1.81 |
Consensus Log Po/w : | 1.3 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.96 |
Solubility : | 1.89 mg/ml ; 0.0109 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.72 |
Solubility : | 3.33 mg/ml ; 0.0192 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.59 |
Solubility : | 0.442 mg/ml ; 0.00255 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.94 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With lithium borohydride; ethanol In tetrahydrofuran at 20℃; for 15 h; | Step 2 To 33 (4.03 g, 20 mmol) in THF (50 mL) in a water bath was added LiBH4 (1.31 g, 60 mmol). Ethanol ( 10 mL) was added to the reaction mixture dropwise and the reaction mixture was stirred at room temperature for 15 h. Excess aqueous IN NaOH was added and the mixture was extracted with EtOAc. The combined organics were washed with water and brine, dried (MgS04), filtered, and concentrated in vacuo to provide 34 (3.43 g, 99percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | Stage #1: With borane-THF In tetrahydrofuran for 3 h; Heating / reflux Stage #2: With water; sodium carbonate In tetrahydrofuranHeating / reflux |
BH3. DMS (1.0 mL, 10.66 mmol) was refluxed in THF (20 mL) for 30 min (formation of BH3. THF). At RT, Example 17 (2.0 g, 10.66 mmol in 10 mL THF) was added dropwise, and then the reaction mixture was heated to reflux for 3 h. The solution was allowed to cool to ambient temperature, solid sodium carbonate (0.5 g) and water (5 mL). The resulting mixture was heated for a short while and poored in water (50 mL). Extraction with ethyl acetate (3 x 50 mL), drying of the combined organic layers (Na2SO4) and evaporation in vacuo gave a 1: 1 mixture of starting material and product. Purification by flash column chromatography over silica gel eluting with ethyl acetate gave 780 mg (42 percent) of an off-white solid. IH NMR (400 MHz, CDC13) 8 3.92 (s, 3H) 4.66 (s, 2H) 6.64 (s, 1H) 6.89 (s, 1H). |
2 g | With borane-THF In tetrahydrofuran at 0 - 20℃; for 20.5 h; Inert atmosphere | To a solution of 2-chloro-6-methoxyisonicotinic acid (2.5 g) in dry tetrahydrofuran (50 ml) at 0°C under nitrogen was added dropwise a solution of borane- tetrahydrofuran complex (1.0M solution in tetrahydrofuran; 40 ml) over fifteen minutes. After the addition was complete, the cooling bath was removed and the mixture allowed to warm to room temperature. After three hours, the mixture was cooled to 0°C and borane-tetrahydrofuran complex (1.0M solution in tetrahydrofuran; 40 ml) was addedover fifteen minutes. After the addition was complete, the cooling bath was removed and the mixture allowed to warm to room temperature and stirred for seventeen hours. The reaction mixture was cooled to 0°C, quenched with 1.0M aqueous sodium hydroxide solution (30 ml), diluted with saturated aqueous ammonium chloride solution (50 ml) and extracted with diethyl ether (2 x 100 ml), the combined organic layer washed with brine then dried (Na2SC"4) and evaporated. The residue was triturated with hexane and filtered to afford (2-chloro-6-methoxypyridin-4-yl)methanol (2.0 g) as a white solid. LCMS: Rt 1.16 min, m/z 174/176 [M+H]+. 1H-NMR (400 MHz, CDC13) δ (ppm): 1.96 (t, 1 H) 3.94 (s, 3 H) 4.67 (d, J=3.67 Hz, 2 H) 6.65 (d, J=0.86 Hz, 1 H) 6.91 (s, 1 H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
28% | With sodium hydroxide In methanol | The starting material was prepared as follows: A mixture of 2,6-dichloro-4-hydroxymethylpyridine (1.72 g, 16 mmol) and 40percent aqueous sodium hydroxide solution (5 ml) in methanol (50 ml) was heated at reflux for 24 hours. The mixture was allowed to cool and the volatiles removed by evaporation. The residue was extracted with ethyl acetate and the solvent removed from the extracts by evaporation. The residue was recrystallized from ethyl acetate/hexane to give 2-chloro-4-hydroxymethyl-6-methoxypyridine (490 mg, 28percent). 1 H NMR Spectrum: (DMSOd6) 3.80(s, 3H); 4.45(d, 2H); 5.45(t, 1H); 6.70(s, 1 H); 6.98(s, 1 H) |
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.92
[ 15855-06-8 ]
2-Chloro-6-methoxypyridine-4-carboxylic Acid
Similarity: 0.86
[ 1228898-61-0 ]
(2-Chloro-6-methoxypyridin-3-yl)methanol
Similarity: 0.83
[ 1256788-36-9 ]
2-Chloro-6-methoxyisonicotinonitrile
Similarity: 0.82
[ 108279-89-6 ]
2-Chloro-4,6-dimethoxypyridine
Similarity: 0.78
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.92
[ 15855-06-8 ]
2-Chloro-6-methoxypyridine-4-carboxylic Acid
Similarity: 0.86
[ 1228898-61-0 ]
(2-Chloro-6-methoxypyridin-3-yl)methanol
Similarity: 0.83
[ 1256788-36-9 ]
2-Chloro-6-methoxyisonicotinonitrile
Similarity: 0.82
[ 108279-89-6 ]
2-Chloro-4,6-dimethoxypyridine
Similarity: 0.78
[ 1228898-61-0 ]
(2-Chloro-6-methoxypyridin-3-yl)methanol
Similarity: 0.83
[ 100704-10-7 ]
(2-Chloropyridin-4-yl)methanol
Similarity: 0.75
[ 21543-49-7 ]
2-Chloro-5-hydroxymethylpyridine
Similarity: 0.71
[ 38076-76-5 ]
6-Chloro-2-hydroxynicotinic acid
Similarity: 0.71
[ 58584-63-7 ]
(6-Methoxypyridin-3-yl)methanol
Similarity: 0.70
[ 25297-52-3 ]
2-Chloro-6-methoxy-4-methylpyridine
Similarity: 0.92
[ 15855-06-8 ]
2-Chloro-6-methoxypyridine-4-carboxylic Acid
Similarity: 0.86
[ 1228898-61-0 ]
(2-Chloro-6-methoxypyridin-3-yl)methanol
Similarity: 0.83
[ 1256788-36-9 ]
2-Chloro-6-methoxyisonicotinonitrile
Similarity: 0.82
[ 108279-89-6 ]
2-Chloro-4,6-dimethoxypyridine
Similarity: 0.78